IBDEI12R ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,17462,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17462,1,3,0)
;;=3^Clubbing of Fingers
;;^UTILITY(U,$J,358.3,17462,1,4,0)
;;=4^R68.3
;;^UTILITY(U,$J,358.3,17462,2)
;;=^5019553
;;^UTILITY(U,$J,358.3,17463,0)
;;=R73.01^^61^787^93
;;^UTILITY(U,$J,358.3,17463,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17463,1,3,0)
;;=3^Impaired Fasting Glucose
;;^UTILITY(U,$J,358.3,17463,1,4,0)
;;=4^R73.01
;;^UTILITY(U,$J,358.3,17463,2)
;;=^5019561
;;^UTILITY(U,$J,358.3,17464,0)
;;=R73.02^^61^787^94
;;^UTILITY(U,$J,358.3,17464,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17464,1,3,0)
;;=3^Impaired Glucose Tolerance (oral)
;;^UTILITY(U,$J,358.3,17464,1,4,0)
;;=4^R73.02
;;^UTILITY(U,$J,358.3,17464,2)
;;=^5019562
;;^UTILITY(U,$J,358.3,17465,0)
;;=R73.09^^61^787^18
;;^UTILITY(U,$J,358.3,17465,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17465,1,3,0)
;;=3^Abnormal Glucose NEC
;;^UTILITY(U,$J,358.3,17465,1,4,0)
;;=4^R73.09
;;^UTILITY(U,$J,358.3,17465,2)
;;=^5019563
;;^UTILITY(U,$J,358.3,17466,0)
;;=R73.9^^61^787^88
;;^UTILITY(U,$J,358.3,17466,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17466,1,3,0)
;;=3^Hyperglycemia,Unspec
;;^UTILITY(U,$J,358.3,17466,1,4,0)
;;=4^R73.9
;;^UTILITY(U,$J,358.3,17466,2)
;;=^5019564
;;^UTILITY(U,$J,358.3,17467,0)
;;=R76.11^^61^787^146
;;^UTILITY(U,$J,358.3,17467,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17467,1,3,0)
;;=3^Positive PPD
;;^UTILITY(U,$J,358.3,17467,1,4,0)
;;=4^R76.11
;;^UTILITY(U,$J,358.3,17467,2)
;;=^5019570
;;^UTILITY(U,$J,358.3,17468,0)
;;=R79.1^^61^787^3
;;^UTILITY(U,$J,358.3,17468,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17468,1,3,0)
;;=3^Abnormal Coagulation Profile
;;^UTILITY(U,$J,358.3,17468,1,4,0)
;;=4^R79.1
;;^UTILITY(U,$J,358.3,17468,2)
;;=^5019591
;;^UTILITY(U,$J,358.3,17469,0)
;;=R82.5^^61^787^73
;;^UTILITY(U,$J,358.3,17469,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17469,1,3,0)
;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
;;^UTILITY(U,$J,358.3,17469,1,4,0)
;;=4^R82.5
;;^UTILITY(U,$J,358.3,17469,2)
;;=^5019605
;;^UTILITY(U,$J,358.3,17470,0)
;;=R82.6^^61^787^29
;;^UTILITY(U,$J,358.3,17470,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17470,1,3,0)
;;=3^Abnormal Urine Levels of Subst of Nonmed Source
;;^UTILITY(U,$J,358.3,17470,1,4,0)
;;=4^R82.6
;;^UTILITY(U,$J,358.3,17470,2)
;;=^5019606
;;^UTILITY(U,$J,358.3,17471,0)
;;=R82.90^^61^787^28
;;^UTILITY(U,$J,358.3,17471,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17471,1,3,0)
;;=3^Abnormal Urine Findings,Unspec
;;^UTILITY(U,$J,358.3,17471,1,4,0)
;;=4^R82.90
;;^UTILITY(U,$J,358.3,17471,2)
;;=^5019609
;;^UTILITY(U,$J,358.3,17472,0)
;;=R82.91^^61^787^52
;;^UTILITY(U,$J,358.3,17472,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17472,1,3,0)
;;=3^Chromoabnormalities of Urine NEC
;;^UTILITY(U,$J,358.3,17472,1,4,0)
;;=4^R82.91
;;^UTILITY(U,$J,358.3,17472,2)
;;=^5019610
;;^UTILITY(U,$J,358.3,17473,0)
;;=R89.9^^61^787^22
;;^UTILITY(U,$J,358.3,17473,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17473,1,3,0)
;;=3^Abnormal Organ/Tissue Specimen Findings,Unspec
;;^UTILITY(U,$J,358.3,17473,1,4,0)
;;=4^R89.9
;;^UTILITY(U,$J,358.3,17473,2)
;;=^5019702
;;^UTILITY(U,$J,358.3,17474,0)
;;=R90.0^^61^787^102
;;^UTILITY(U,$J,358.3,17474,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17474,1,3,0)
;;=3^Intracranial Space-Occupying Lesion Dx Imaging of Central Nervous System
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI12R 3808 printed Apr 09, 2024@21:32:53 Page 2
IBDEI12R ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,17462,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,17462,1,3,0)
+4 ;;=3^Clubbing of Fingers
+5 ;;^UTILITY(U,$J,358.3,17462,1,4,0)
+6 ;;=4^R68.3
+7 ;;^UTILITY(U,$J,358.3,17462,2)
+8 ;;=^5019553
+9 ;;^UTILITY(U,$J,358.3,17463,0)
+10 ;;=R73.01^^61^787^93
+11 ;;^UTILITY(U,$J,358.3,17463,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,17463,1,3,0)
+14 ;;=3^Impaired Fasting Glucose
+15 ;;^UTILITY(U,$J,358.3,17463,1,4,0)
+16 ;;=4^R73.01
+17 ;;^UTILITY(U,$J,358.3,17463,2)
+18 ;;=^5019561
+19 ;;^UTILITY(U,$J,358.3,17464,0)
+20 ;;=R73.02^^61^787^94
+21 ;;^UTILITY(U,$J,358.3,17464,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,17464,1,3,0)
+24 ;;=3^Impaired Glucose Tolerance (oral)
+25 ;;^UTILITY(U,$J,358.3,17464,1,4,0)
+26 ;;=4^R73.02
+27 ;;^UTILITY(U,$J,358.3,17464,2)
+28 ;;=^5019562
+29 ;;^UTILITY(U,$J,358.3,17465,0)
+30 ;;=R73.09^^61^787^18
+31 ;;^UTILITY(U,$J,358.3,17465,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,17465,1,3,0)
+34 ;;=3^Abnormal Glucose NEC
+35 ;;^UTILITY(U,$J,358.3,17465,1,4,0)
+36 ;;=4^R73.09
+37 ;;^UTILITY(U,$J,358.3,17465,2)
+38 ;;=^5019563
+39 ;;^UTILITY(U,$J,358.3,17466,0)
+40 ;;=R73.9^^61^787^88
+41 ;;^UTILITY(U,$J,358.3,17466,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,17466,1,3,0)
+44 ;;=3^Hyperglycemia,Unspec
+45 ;;^UTILITY(U,$J,358.3,17466,1,4,0)
+46 ;;=4^R73.9
+47 ;;^UTILITY(U,$J,358.3,17466,2)
+48 ;;=^5019564
+49 ;;^UTILITY(U,$J,358.3,17467,0)
+50 ;;=R76.11^^61^787^146
+51 ;;^UTILITY(U,$J,358.3,17467,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,17467,1,3,0)
+54 ;;=3^Positive PPD
+55 ;;^UTILITY(U,$J,358.3,17467,1,4,0)
+56 ;;=4^R76.11
+57 ;;^UTILITY(U,$J,358.3,17467,2)
+58 ;;=^5019570
+59 ;;^UTILITY(U,$J,358.3,17468,0)
+60 ;;=R79.1^^61^787^3
+61 ;;^UTILITY(U,$J,358.3,17468,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,17468,1,3,0)
+64 ;;=3^Abnormal Coagulation Profile
+65 ;;^UTILITY(U,$J,358.3,17468,1,4,0)
+66 ;;=4^R79.1
+67 ;;^UTILITY(U,$J,358.3,17468,2)
+68 ;;=^5019591
+69 ;;^UTILITY(U,$J,358.3,17469,0)
+70 ;;=R82.5^^61^787^73
+71 ;;^UTILITY(U,$J,358.3,17469,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,17469,1,3,0)
+74 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
+75 ;;^UTILITY(U,$J,358.3,17469,1,4,0)
+76 ;;=4^R82.5
+77 ;;^UTILITY(U,$J,358.3,17469,2)
+78 ;;=^5019605
+79 ;;^UTILITY(U,$J,358.3,17470,0)
+80 ;;=R82.6^^61^787^29
+81 ;;^UTILITY(U,$J,358.3,17470,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,17470,1,3,0)
+84 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
+85 ;;^UTILITY(U,$J,358.3,17470,1,4,0)
+86 ;;=4^R82.6
+87 ;;^UTILITY(U,$J,358.3,17470,2)
+88 ;;=^5019606
+89 ;;^UTILITY(U,$J,358.3,17471,0)
+90 ;;=R82.90^^61^787^28
+91 ;;^UTILITY(U,$J,358.3,17471,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,17471,1,3,0)
+94 ;;=3^Abnormal Urine Findings,Unspec
+95 ;;^UTILITY(U,$J,358.3,17471,1,4,0)
+96 ;;=4^R82.90
+97 ;;^UTILITY(U,$J,358.3,17471,2)
+98 ;;=^5019609
+99 ;;^UTILITY(U,$J,358.3,17472,0)
+100 ;;=R82.91^^61^787^52
+101 ;;^UTILITY(U,$J,358.3,17472,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,17472,1,3,0)
+104 ;;=3^Chromoabnormalities of Urine NEC
+105 ;;^UTILITY(U,$J,358.3,17472,1,4,0)
+106 ;;=4^R82.91
+107 ;;^UTILITY(U,$J,358.3,17472,2)
+108 ;;=^5019610
+109 ;;^UTILITY(U,$J,358.3,17473,0)
+110 ;;=R89.9^^61^787^22
+111 ;;^UTILITY(U,$J,358.3,17473,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,17473,1,3,0)
+114 ;;=3^Abnormal Organ/Tissue Specimen Findings,Unspec
+115 ;;^UTILITY(U,$J,358.3,17473,1,4,0)
+116 ;;=4^R89.9
+117 ;;^UTILITY(U,$J,358.3,17473,2)
+118 ;;=^5019702
+119 ;;^UTILITY(U,$J,358.3,17474,0)
+120 ;;=R90.0^^61^787^102
+121 ;;^UTILITY(U,$J,358.3,17474,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,17474,1,3,0)
+124 ;;=3^Intracranial Space-Occupying Lesion Dx Imaging of Central Nervous System
